- Capricor Therapeutics Reports First Quarter 2023 Financial Results ...🔍
- Capricor Therapeutics to Present First Quarter 2023 Financial ...🔍
- Capricor Therapeutics First Quarter 2023 Financial Results and ...🔍
- Capricor Therapeutics Reports First Quarter 2024 Financial Results ...🔍
- Financial Results🔍
- Capricor Therapeutics Reports First Quarter 2024 Financial🔍
- Capricor Therapeutics Reports Third Quarter 2024 Financial Results ...🔍
- Capricor Therapeutics Reports Third Quarter 2024 Financial🔍
Capricor Therapeutics Reports First Quarter 2023 Financial Results ...
Capricor Therapeutics Reports First Quarter 2023 Financial Results ...
The Company's cash, cash equivalents and marketable securities totaled approximately $45.2 million as of March 31, 2023 compared to approximately $41.4 million ...
Capricor Therapeutics to Present First Quarter 2023 Financial ...
Company to Host Conference Call, May 11, 2023, at 4:30 p.m. ET SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: ...
Capricor Therapeutics First Quarter 2023 Financial Results and ...
Capricor Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call ; Earnings Release · PDF ; 10-Q Filing · PDF ; XBRL.
Capricor Therapeutics Reports First Quarter 2024 Financial Results ...
Related Documents · Capricor will receive a meaningful mid-range double-digit share of product revenue. · As previously disclosed, there is an ...
Capricor Therapeutics Reports First Quarter 2023 Financial Results ...
Enrollment Continues to Progress in HOPE-3, the Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy (DMD); On Track to Report ...
Financial Results - Capricor Therapeutics
Quarter Ended Jun 30, 2024. Earnings Release · PDF HTML · Earnings Webcast · Audio · 10-Q Filing · PDF HTML · XBRL · ZIP. Q1 2024. Quarter Ended Mar 31, ...
Capricor Therapeutics Reports First Quarter 2024 Financial
CAPRICOR THERAPEUTICS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS. (UNAUDITED). Three months ended March 31,.
Capricor Therapeutics Reports Third Quarter 2024 Financial Results ...
Revenues: Revenues for the third quarter of 2024 were approximately $2.3 million compared to $6.2 million for the third quarter of 2023.
Capricor Therapeutics Reports Third Quarter 2024 Financial
Revenues: Revenues for the third quarter of 2024 were approximately $2.3 million compared to $6.2 million for the third quarter of 2023.
Capricor Therapeutics to Present First Quarter 2024 Financial ...
Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13. May 06, 2024 9:00 am EDT Download as PDF ...
Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
The accompanying unaudited interim condensed consolidated financial statements for Capricor Therapeutics ... On February 10, 2023, Capricor ...
CAPR Q1-2023 Earnings Call - Alpha Spread
Capricor Therapeutics Inc (NASDAQ:CAPR) Q1-2023 earnings call transcript ... Welcome to Capricor First Quarter 2023 Financial Results and Corporate Update Call.
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 ...
Net loss: The Company reported a net loss of approximately $0.8 million, or $0.02 per share, for the fourth quarter of 2023, compared to a net ...
Capricor Therapeutics Reports Second Quarter 2023 Financial ...
We recently held a clinical meeting with the U.S. Food and Drug Administration. (FDA) to discuss these results, together with key features of ...
Capricor Therapeutics Reports Second Quarter 2024 Financial ...
Capricor's Q2 2024 results show mixed financial performance. Revenue increased slightly to $4.0 million from $3.9 million year-over-year, ...
99.1. Press Release, titled “Capricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update”, dated May. 11, ...
Quarterly Results | Zevra Therapeutics, Inc.
2023 · Q1. Zevra Therapeutics Reports Corporate Updates and First Quarter 2023 Financial Results · Zevra Therapeutics Q1 2023 Earnings Call · Q2. Zevra ...
CAPR / Capricor Therapeutics, Inc. - SEC Filings, Annual Report ...
Capricor Therapeutics, Inc. 2023-09-29, 424B5, 4,935,621 Shares of Common Stock ... Capricor Therapeutics Reports Third Quarter 2014 Financial & Business ...
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2023 Earnings ...
Published on May 17, 2023 at 3:21 pm by Insider Monkey Transcripts in News, ... Capricor Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Press Releases :: Capricor Therapeutics, Inc. (CAPR)
May 11, 2023 4:01 pm EDT. Capricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update. May 04, 2023 9:00 am EDT. Capricor ...